These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 17895124)

  • 21. Thrombolysis (tissue plasminogen activator) in stroke: a medicolegal quagmire.
    Weintraub MI
    Stroke; 2006 Jul; 37(7):1917-22. PubMed ID: 16728683
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The safety and efficacy of tPA intravenous thrombolysis for treating acute ischemic stroke patients with a history of cerebral hemorrhage.
    Zhao GJ; Wang ZR; Lin FZ; Cui YS; Xu SL
    Braz J Med Biol Res; 2019 Jan; 52(2):e7739. PubMed ID: 30698226
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Retrosternal mass: An interesting allergic reaction to intravenous thrombolytic therapy for acute ischemic stroke.
    Mehrpour M; Motamed MR; Aghaei M; Badi Z
    Iran J Neurol; 2013; 12(3):114-6. PubMed ID: 24250917
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Elevated international normalized ratio as a manifestation of post-thrombolytic coagulopathy in acute ischemic stroke.
    Lee VH; Conners JJ; Cutting S; Song SY; Bernstein RA; Prabhakaran S
    J Stroke Cerebrovasc Dis; 2014 Sep; 23(8):2139-2144. PubMed ID: 25081309
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tissue Plasminogen Activator-Porous Magnetic Microrods for Targeted Thrombolytic Therapy after Ischemic Stroke.
    Hu J; Huang S; Zhu L; Huang W; Zhao Y; Jin K; ZhuGe Q
    ACS Appl Mater Interfaces; 2018 Oct; 10(39):32988-32997. PubMed ID: 30192506
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intravenous tissue-type plasminogen activator therapy for ischemic stroke: Houston experience 1996 to 2000.
    Grotta JC; Burgin WS; El-Mitwalli A; Long M; Campbell M; Morgenstern LB; Malkoff M; Alexandrov AV
    Arch Neurol; 2001 Dec; 58(12):2009-13. PubMed ID: 11735774
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Perfusion computed tomography-guided intravenous thrombolysis for acute ischemic stroke beyond 4.5 hours: a case-control study.
    García-Bermejo P; Calleja AI; Pérez-Fernández S; Cortijo E; del Monte JM; García-Porrero M; Fe Muñoz M; Fernández-Herranz R; Arenillas JF
    Cerebrovasc Dis; 2012; 34(1):31-7. PubMed ID: 22759450
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Guidelines for the use of intravenous thrombolytic agents in acute myocardial infarction. Ontario Medical Association Consensus Group on Thrombolytic Therapy.
    Naylor CD; Armstrong PW
    CMAJ; 1989 Jun; 140(11):1289-99. PubMed ID: 2497946
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Aortic transgraft hemorrhage after intravenous tissue plasminogen activator therapy in patients with acute ischemic stroke.
    Kawano T; Kajimoto K; Higashi M; Minatoya K; Toyoda K; Nagatsuka K
    J Stroke Cerebrovasc Dis; 2014 Sep; 23(8):2145-2150. PubMed ID: 25088170
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tissue plasminogen activator for acute ischemic stroke: a New York city emergency medicine perspective.
    Chan YF; Kwiatkowski TG; Rella JG; Rennie WP; Kwon RK; Silverman RA
    J Emerg Med; 2005 Nov; 29(4):405-8. PubMed ID: 16243196
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Utilization of intravenous tissue plasminogen activator for acute ischemic stroke.
    Katzan IL; Hammer MD; Hixson ED; Furlan AJ; Abou-Chebl A; Nadzam DM;
    Arch Neurol; 2004 Mar; 61(3):346-50. PubMed ID: 15023810
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Temporal trends in patient characteristics and treatment with intravenous thrombolysis among acute ischemic stroke patients at Get With The Guidelines-Stroke hospitals.
    Schwamm LH; Ali SF; Reeves MJ; Smith EE; Saver JL; Messe S; Bhatt DL; Grau-Sepulveda MV; Peterson ED; Fonarow GC
    Circ Cardiovasc Qual Outcomes; 2013 Sep; 6(5):543-9. PubMed ID: 24046398
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Economic benefit of increasing utilization of intravenous tissue plasminogen activator for acute ischemic stroke in the United States.
    Demaerschalk BM; Yip TR
    Stroke; 2005 Nov; 36(11):2500-3. PubMed ID: 16224087
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of tissue-type plasminogen activator for acute ischemic stroke: the Cleveland area experience.
    Katzan IL; Furlan AJ; Lloyd LE; Frank JI; Harper DL; Hinchey JA; Hammel JP; Qu A; Sila CA
    JAMA; 2000 Mar; 283(9):1151-8. PubMed ID: 10703777
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intravenous Thrombolysis Increases the Rate of Dramatic Recovery in Patients with Acute Stroke with an Unknown Onset Time and Negative FLAIR MRI.
    Aoki J; Sakamoto Y; Kimura K
    J Neuroimaging; 2016 Jul; 26(4):414-9. PubMed ID: 27388586
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Optimizing the management of acute ischaemic stroke: a review of the utilization of intravenous recombinant tissue plasminogen activator (tPA).
    Eissa A; Krass I; Bajorek BV
    J Clin Pharm Ther; 2012 Dec; 37(6):620-9. PubMed ID: 22708668
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cost-effectiveness of thrombolysis within 4.5 hours of acute ischemic stroke: experience from Australian stroke center.
    Tan Tanny SP; Busija L; Liew D; Teo S; Davis SM; Yan B
    Stroke; 2013 Aug; 44(8):2269-74. PubMed ID: 23780955
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A review of barriers to thrombolytic therapy: implications for nursing care in the emergency department.
    Johnson M; Bakas T
    J Neurosci Nurs; 2010 Apr; 42(2):88-94. PubMed ID: 20422794
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intravenous Thrombolysis for Stroke and Presumed Stroke in Human Immunodeficiency Virus-Infected Adults: A Retrospective, Multicenter US Study.
    AbdelRazek MA; Gutierrez J; Mampre D; Cervantes-Arslanian A; Ormseth C; Haussen D; Thakur KT; Lyons JL; Smith BR; O'Connor O; Willey JZ; Mateen FJ
    Stroke; 2018 Jan; 49(1):228-231. PubMed ID: 29273597
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of Acute Ischemic Stroke Care and Outcomes Between Comprehensive Stroke Centers and Primary Stroke Centers in the United States.
    Man S; Zhao X; Uchino K; Hussain MS; Smith EE; Bhatt DL; Xian Y; Schwamm LH; Shah S; Khan Y; Fonarow GC
    Circ Cardiovasc Qual Outcomes; 2018 Jun; 11(6):e004512. PubMed ID: 29794035
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.